cinacalcet has been researched along with Deficiency, Vitamin D in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 12 (70.59) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, M; Blake, L; Griffin, DG; Griffin, TP; Mulkerrin, E; Murray, H; O'Shea, PM | 1 |
| Hamano, T; Lim, K; Thadhani, R | 1 |
| Cetani, F; Marcocci, C; Saponaro, F | 1 |
| Crouzeix, G; Kerlan, V | 1 |
| Lhotta, K; Mündle, M; Sprenger-Mähr, H; Zitt, E | 1 |
| Shaheen, FA; Souqiyyeh, MZ | 1 |
| Andres, A; Gutierrez, E; Morales, E | 1 |
| Bolivar, I; Goltzman, D; Nguyen-Yamamoto, L; Strugnell, SA | 1 |
| Thomsen, Sv; Vestergaard, P | 1 |
| Casanueva, FF; García López, JM; García Vázquez, M; Prieto Tenreiro, AM; Puñal Rodríguez, JA | 1 |
| Hu, B; Hu, P; Lu, L; Qin, YH; Wang, J; Xuan, Q | 1 |
| Bian, A; Ellis, CD; Hung, AM; Ikizler, TA; Plotnikova, NE; Shintani, A; Siew, ED; Sundell, MB | 1 |
| Drüeke, TB | 1 |
| González, EA; Martin, KJ; Wood, C | 1 |
| Fournier, A; Harbouche, L; Monge, M; Shahapuni, I | 1 |
| Akizawa, T; Kinugasa, E; Koiwa, F; Ogata, H | 1 |
| Bonny, O; Burnier, M | 1 |
8 review(s) available for cinacalcet and Deficiency, Vitamin D
| Article | Year |
|---|---|
Vitamin D and Calcimimetics in Cardiovascular Disease.
Topics: Animals; Calcimimetic Agents; Cardiovascular Diseases; Cinacalcet; Clinical Trials as Topic; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Renal Insufficiency; Vascular Calcification; Ventricular Remodeling; Vitamin D; Vitamin D Deficiency; Vitamins | 2018 |
Non-surgical management of primary hyperparathyroidism.
Topics: Calcium; Cinacalcet; Female; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Parathyroid Hormone; Parathyroidectomy; Pregnancy; Pregnancy Complications; Vitamin D Deficiency | 2018 |
Treatment with calcimimetics in kidney transplantation.
Topics: Bone Diseases; Bone Diseases, Metabolic; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Graft Survival; Humans; Hypercalcemia; Hyperparathyroidism; Hypophosphatemia; Kidney Transplantation; Minerals; Naphthalenes; Postoperative Complications; Survival Analysis; Vitamin D Deficiency | 2010 |
Medical treatment of primary, secondary, and tertiary hyperparathyroidism.
Topics: Animals; Calcium; Cinacalcet; Humans; Hyperparathyroidism; Naphthalenes; Parathyroid Hormone; Receptors, Calcium-Sensing; Severity of Illness Index; Vitamin D; Vitamin D Deficiency | 2011 |
Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease.
Topics: Animals; Calcimimetic Agents; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Diet; Endothelium, Vascular; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Kidney Transplantation; Male; Naphthalenes; Parathyroid Hormone; Phosphates; Polyamines; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification; Vitamin D; Vitamin D Deficiency | 2012 |
Calcimimetics versus vitamin D: what are their relative roles?
Topics: Calcitriol; Cinacalcet; Clinical Trials as Topic; Drug Synergism; Ergocalciferols; Humans; Hydroxycholecalciferols; Hypercalcemia; Hyperparathyroidism, Secondary; Intestinal Absorption; Kidney Failure, Chronic; Liver; Naphthalenes; Phosphates; Receptors, Calcitriol; Receptors, Calcium-Sensing; Vitamin D; Vitamin D Deficiency | 2004 |
CKD-MBD: impact on management of kidney disease.
Topics: Aniline Compounds; Bone Diseases, Metabolic; Calcium Metabolism Disorders; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Lanthanum; Naphthalenes; Phenethylamines; Polyamines; Propylamines; Renal Insufficiency, Chronic; Sevelamer; Vitamin D; Vitamin D Deficiency; Vitamins | 2007 |
[Treatment of secondary hyperparathyroidism in renal insufficiency: role of calcitriol, sevelamer and cinacalcet].
Topics: Calcitriol; Chelating Agents; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Naphthalenes; Polyamines; Renal Insufficiency; Sevelamer; Vitamin D Deficiency; Vitamins | 2008 |
1 trial(s) available for cinacalcet and Deficiency, Vitamin D
| Article | Year |
|---|---|
A pilot study of active vitamin D administration and insulin resistance in African American patients undergoing chronic hemodialysis.
Topics: Absorptiometry, Photon; Adipokines; Biomarkers; Black or African American; Body Composition; Cardiovascular Diseases; Chronic Disease; Cinacalcet; Double-Blind Method; Endpoint Determination; Female; Glucose Clamp Technique; Humans; Hyperinsulinism; Inflammation; Insulin Resistance; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Pilot Projects; Receptors, Calcium-Sensing; Renal Dialysis; Risk Factors; Vitamin D; Vitamin D Deficiency | 2013 |
8 other study(ies) available for cinacalcet and Deficiency, Vitamin D
| Article | Year |
|---|---|
Normocalcemia in the Face of Marked Hypervitaminosis D: The Utility of Vitamin D Metabolite Profiling.
Topics: Aged, 80 and over; Calcium; Cholecalciferol; Cinacalcet; Dietary Supplements; Dose-Response Relationship, Drug; Ergocalciferols; Female; Humans; Hyperparathyroidism; Nutrition Disorders; Parathyroid Hormone; Vitamin D; Vitamin D Deficiency | 2019 |
[Primary hyperparathyroidism: new concepts, new recommendations].
Topics: Adult; Aged; Bone Density; Calcium; Cinacalcet; Diphosphonates; Endocrinology; Fractures, Bone; General Surgery; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant; Infant, Newborn; Lithiasis; Middle Aged; Naphthalenes; Nephrocalcinosis; Practice Guidelines as Topic; Risk Factors; Societies, Medical; Vitamin D Deficiency | 2014 |
Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency.
Topics: Administration, Oral; Aged; Aged, 80 and over; Body Weight; Calcifediol; Calcimimetic Agents; Calcitriol; Calcium; Cholecalciferol; Cinacalcet; Drug Dosage Calculations; Drug Substitution; Female; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Vitamin D Deficiency; Vitamins | 2015 |
Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Topics: Attitude of Health Personnel; Biomarkers; Bone Diseases, Metabolic; Calcium; Chelating Agents; Chronic Disease; Cinacalcet; Evidence-Based Medicine; Glomerular Filtration Rate; Guideline Adherence; Health Care Surveys; Health Knowledge, Attitudes, Practice; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Practice Patterns, Physicians'; Renal Dialysis; Saudi Arabia; Surveys and Questionnaires; Treatment Outcome; Vitamin D; Vitamin D Deficiency | 2010 |
Comparison of active vitamin D compounds and a calcimimetic in mineral homeostasis.
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcification, Physiologic; Cinacalcet; Homeostasis; Mice; Mutation; Naphthalenes; Osteoblasts; Osteoclasts; Parathyroid Glands; Vitamin D; Vitamin D Deficiency | 2010 |
[The value of selective parathyroid venous sampling for localizing occult parathyroid adenomas].
Topics: Adenoma; Aged; Blood Specimen Collection; Catheterization, Peripheral; Cinacalcet; False Negative Reactions; Female; Goiter, Nodular; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Magnetic Resonance Imaging; Naphthalenes; Neoplasm Recurrence, Local; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Preoperative Care; Radionuclide Imaging; Reoperation; Thyroidectomy; Veins; Vitamin D Deficiency | 2012 |
Challenges in the therapy of secondary hyperparathyroidism.
Topics: Bone and Bones; Bone Density; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphate-Binding Proteins; Phosphates; Practice Guidelines as Topic; Renal Dialysis; Risk Factors; Vitamin D; Vitamin D Deficiency | 2005 |
Calcimimetics for predialysis patients?
Topics: Calcifediol; Chronic Disease; Cinacalcet; Dose-Response Relationship, Drug; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphates; Vitamin D; Vitamin D Deficiency | 2006 |